CVS Health Corp (CVS)

In the past 90 days, CVS Health Corp has recorded two insider trading transactions, totaling a net value of approximately $1.5 million. Notably, Michael F. Mahoney purchased 30,000 shares for $2,001,000 on February 18, 2025, while James David Clark sold 7,513 shares for $498,487.55 on March 5, 2025. The company's stock has increased by 34.3% over the last 90 days, and the last earnings report on February 5, 2025, showed a 29.56% earnings per share beat.

Healthcare Healthcare Services Healthcare Providers & Services

Track

Stock chart

Ticker: CVS Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-03-07	2025-03-05	S Sale	Clark James David SVP, Cont & Chief Acct Officer Officer	7,513 -47.2% 66.35 USD 498,488	7,513 -47.2%	66.35	USD 498,488
2025-02-19	2025-02-18	B Purchase	Mahoney Michael F Non-Executive Director	30,000 +320.6% 66.70 USD 2,001,000	30,000 +320.6%	66.70	USD 2,001,000
2024-05-02	2024-05-02	B Purchase	LUDWIG EDWARD J Non-Executive Director	1,000 +4.8% 53.88 USD 53,879	1,000 +4.8%	53.88	USD 53,879
2024-05-02	2024-05-02	B Purchase	Mahoney Michael F Non-Executive Director	9,181 +5246.3% 54.49 USD 500,294	9,181 +5246.3%	54.49	USD 500,294
2024-02-16	2024-02-16	S Sale	Shah Prem S EVP and Pres-Pharm, Consumer W Officer	29,473 -42.6% 76.95 USD 2,267,947	29,473 -42.6%	76.95	USD 2,267,947
2023-11-06	2023-11-03	B Purchase	LUDWIG EDWARD J Non-Executive Director	2,000 +10.7% 70.47 USD 140,930	2,000 +10.7%	70.47	USD 140,930
2023-08-04	2023-08-03	S Sale	Clark James David SVP, Cont & Chief Acct Officer Officer	23,128 -83.1% 74.94 USD 1,733,212	23,128 -83.1%	74.94	USD 1,733,212
2023-08-04	2023-08-03	S Sale	Clark James David SVP, Cont & Chief Acct Officer Officer	2,631 -8.6% 74.79 USD 196,792	2,631 -8.6%	74.79	USD 196,792
2023-05-05	2023-05-03	B Purchase	Lynch Karen S President and CEO Executive Director	14,000 +3.4% 69.75 USD 976,567	14,000 +3.4%	69.75	USD 976,567
2022-12-16	2022-12-15	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	36,490 -5.7% 98.24 USD 3,584,869	36,490 -5.7%	98.24	USD 3,584,869
2022-12-16	2022-12-15	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	100,976 -14.2% 98.40 USD 9,936,311	100,976 -14.2%	98.40	USD 9,936,311
2022-08-05	2022-08-04	PS Planned sale	Lotvin Alan EVP&President-PharmacyServices Officer	22,541 -17.1% 104.00 USD 2,344,264	22,541 -17.1%	104.00	USD 2,344,264
2022-08-05	2022-08-03	PS Planned sale	Lotvin Alan EVP&President-PharmacyServices Officer	50,501 -31.6% 98.00 USD 4,949,098	50,501 -31.6%	98.00	USD 4,949,098
2022-08-05	2022-08-03	PS Planned sale	Lotvin Alan EVP&President-PharmacyServices Officer	70,398 -39.2% 98.00 USD 6,899,004	70,398 -39.2%	98.00	USD 6,899,004
2022-08-05	2022-08-03	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	9,546 -22.9% 100.00 USD 954,600	9,546 -22.9%	100.00	USD 954,600
2022-04-12	2022-04-08	PS Planned sale	Shah Prem S EVP and Co-President of Retail Officer	3,130 -6.7% 105.00 USD 328,650	3,130 -6.7%	105.00	USD 328,650
2022-04-12	2022-04-08	PS Planned sale	Shah Prem S EVP and Co-President of Retail Officer	4,103 -8.1% 105.00 USD 430,815	4,103 -8.1%	105.00	USD 430,815
2022-04-12	2022-04-08	PS Planned sale	Shah Prem S EVP and Co-President of Retail Officer	5,719 -10.9% 105.00 USD 600,495	5,719 -10.9%	105.00	USD 600,495
2022-04-12	2022-04-08	PS Planned sale	Shah Prem S EVP and Co-President of Retail Officer	3,157 -6.3% 105.00 USD 331,485	3,157 -6.3%	105.00	USD 331,485
2022-04-12	2022-04-08	PS Planned sale	Shah Prem S EVP and Co-President of Retail Officer	845 -1.8% 105.00 USD 88,725	845 -1.8%	105.00	USD 88,725
2022-04-06	2022-04-05	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	5,941 -15.6% 100.00 USD 594,100	5,941 -15.6%	100.00	USD 594,100
2022-04-06	2022-04-04	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	12,032 -24.0% 100.13 USD 1,204,764	12,032 -24.0%	100.13	USD 1,204,764
2022-04-06	2022-04-04	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	27,166 -35.1% 100.13 USD 2,720,132	27,166 -35.1%	100.13	USD 2,720,132
2022-04-06	2022-04-04	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	16,161 -24.4% 100.13 USD 1,618,201	16,161 -24.4%	100.13	USD 1,618,201
2022-03-18	2022-03-17	S Sale	Shah Prem S EVP and Co-President of Retail Officer	2,935 -4.7% 106.65 USD 313,018	2,935 -4.7%	106.65	USD 313,018
2022-03-18	2022-03-17	S Sale	Shah Prem S EVP and Co-President of Retail Officer	1,689 -2.8% 106.65 USD 180,132	1,689 -2.8%	106.65	USD 180,132
2022-03-17	2022-03-15	S Sale	Moriarty Thomas M EVP & General Counsel Officer	51,361 -5.8% 105.00 USD 5,392,905	51,361 -5.8%	105.00	USD 5,392,905
2022-02-11	2022-02-10	B Purchase	LUDWIG EDWARD J Non-Executive Director	1,000 +5.8% 105.90 USD 105,904	1,000 +5.8%	105.90	USD 105,904
2022-02-04	2022-02-03	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	47,937 -25.7% 110.00 USD 5,273,070	47,937 -25.7%	110.00	USD 5,273,070
2022-02-02	2022-02-01	PS Planned sale	Lotvin Alan EVP&President-PharmacyServices Officer	21,386 -25.9% 106.50 USD 2,277,566	21,386 -25.9%	106.50	USD 2,277,566
2022-02-01	2022-01-28	PS Planned sale	Clark James David SVP, Cont & Chief Acct Officer Officer	6,059 -25.7% 109.00 USD 660,431	6,059 -25.7%	109.00	USD 660,431
2022-01-28	2022-01-27	PS Planned sale	Roberts Jonathan C EVP & Chief Operating Officer Officer	68,482 -39.0% 107.50 USD 7,361,815	68,482 -39.0%	107.50	USD 7,361,815
2021-11-05	2021-11-03	PS Planned sale	Roberts Jonathan C EVP & Chief Operating Officer Officer	108,870 -50.4% 95.00 USD 10,342,650	108,870 -50.4%	95.00	USD 10,342,650
2021-11-03	2021-11-01	S Sale	Brennan Troyen A EVP and Chief Medical Officer Officer	28,159 -16.9% 90.00 USD 2,534,310	28,159 -16.9%	90.00	USD 2,534,310
2021-10-28	2021-10-26	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	80,802 -36.9% 88.00 USD 7,110,576	80,802 -36.9%	88.00	USD 7,110,576
2021-10-28	2021-10-26	S Sale	Brennan Troyen A EVP and Chief Medical Officer Officer	1,955 -0.9% 88.00 USD 172,040	1,955 -0.9%	88.00	USD 172,040
2021-06-29	2021-06-28	PS Planned sale	Lotvin Alan EVP&President-PharmacyServices Officer	2,781 -4.4% 83.67 USD 232,686	2,781 -4.4%	83.67	USD 232,686
2021-06-17	2021-06-15	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	67,552 -32.1% 86.00 USD 5,809,472	67,552 -32.1%	86.00	USD 5,809,472
2021-06-08	2021-06-07	PS Planned sale	Finke Daniel P EVP/Pres, Health Care Benefits Officer	37,594 -61.7% 86.60 USD 3,255,640	37,594 -61.7%	86.60	USD 3,255,640
2021-05-12	2021-05-10	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	109,469 -100.0% 86.00 USD 9,414,334	109,469 -100.0%	86.00	USD 9,414,334
2021-05-10	2021-05-07	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	9,477 -6.1% 84.00 USD 796,068	9,477 -6.1%	84.00	USD 796,068
2021-05-06	2021-05-04	PS Planned sale	Boratto Eva C EVP & CFO Officer	4,905 -4.1% 80.00 USD 392,400	4,905 -4.1%	80.00	USD 392,400
2021-04-23	2021-04-21	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	2,420 -100.0% 77.00 USD 186,340	2,420 -100.0%	77.00	USD 186,340
2021-04-23	2021-04-21	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	101,003 -97.7% 77.00 USD 7,777,231	101,003 -97.7%	77.00	USD 7,777,231
2021-04-01	2021-03-31	PS Planned sale	Clark James David SVP, Cont & Chief Acct Officer Officer	5,350 -42.5% 76.00 USD 406,600	5,350 -42.5%	76.00	USD 406,600
2021-03-30	2021-03-29	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	62,943 -100.0% 76.15 USD 4,793,109	62,943 -100.0%	76.15	USD 4,793,109
2021-03-29	2021-03-26	PS Planned sale	MERLO LARRY J Non-Executive Director	270,650 -34.1% 74.73 USD 20,225,675	270,650 -34.1%	74.73	USD 20,225,675
2021-03-29	2021-03-26	PS Planned sale	Roberts Jonathan C EVP & Chief Operating Officer Officer	73,433 -99.1% 74.49 USD 5,470,024	73,433 -99.1%	74.49	USD 5,470,024
2021-03-23	2021-03-19	PS Planned sale	Moriarty Thomas M EVP & General Counsel Officer	49,211 -73.0% 74.15 USD 3,648,996	49,211 -73.0%	74.15	USD 3,648,996
2021-03-17	2021-03-16	PS Planned sale	Boratto Eva C EVP & CFO Officer	18,882 -21.0% 74.68 USD 1,410,108	18,882 -21.0%	74.68	USD 1,410,108
2021-02-17	2021-02-17	B Purchase	LUDWIG EDWARD J Non-Executive Director	3,000 +26.5% 72.00 USD 216,000	3,000 +26.5%	72.00	USD 216,000
2021-01-21	2021-01-19	PS Planned sale	MERLO LARRY J President and CEO Executive Director	62,893 -10.7% 77.00 USD 4,842,761	62,893 -10.7%	77.00	USD 4,842,761
2021-01-13	2021-01-12	PS Planned sale	Bisaccia Lisa EVP and Chief HR Officer Officer	25,177 -35.1% 77.00 USD 1,938,629	25,177 -35.1%	77.00	USD 1,938,629
2021-01-12	2021-01-08	PS Planned sale	Lotvin Alan EVP and President-CVS Caremark Officer	25,836 -75.5% 75.00 USD 1,937,700	25,836 -75.5%	75.00	USD 1,937,700
2021-01-12	2021-01-08	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	58,896 -56.1% 75.00 USD 4,417,200	58,896 -56.1%	75.00	USD 4,417,200
2020-11-17	2020-11-13	PS Planned sale	Lotvin Alan EVP and President-CVS Caremark Officer	7,138 -47.1% 70.00 USD 499,660	7,138 -47.1%	70.00	USD 499,660
2020-11-12	2020-11-10	PS Planned sale	Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL Officer	21,460 -46.2% 70.00 USD 1,502,200	21,460 -46.2%	70.00	USD 1,502,200
2020-05-28	2020-05-26	PS Planned sale	Clark James David SVP, Cont & Chief Acct Officer Officer	270 -5.6% 65.00 USD 17,550	270 -5.6%	65.00	USD 17,550
2020-05-28	2020-05-26	PS Planned sale	Mayhew Jonathan E. EVP - Transformation Officer	10,556 -69.0% 65.00 USD 686,140	10,556 -69.0%	65.00	USD 686,140
2020-05-13	2020-05-11	B Purchase	Lotvin Alan EVP and President-CVS Caremark Officer	5,000 +49.2% 63.14 USD 315,675	5,000 +49.2%	63.14	USD 315,675
2020-04-30	2020-04-28	PS Planned sale	Clark James David SVP, Cont & Chief Acct Officer Officer	6,234 -56.4% 65.00 USD 405,210	6,234 -56.4%	65.00	USD 405,210
2020-04-01	2020-03-30	PS Planned sale	Clark James David SVP, Cont & Chief Acct Officer Officer	3,030 -23.7% 60.00 USD 181,800	3,030 -23.7%	60.00	USD 181,800
2020-01-17	2020-01-15	PS Planned sale	MERLO LARRY J President and CEO Executive Director	266,476 -37.9% 74.79 USD 19,929,740	266,476 -37.9%	74.79	USD 19,929,740
2020-01-10	2020-01-08	PS Planned sale	Roberts Jonathan C EVP & Chief Operating Officer	57,563 -56.1% 72.63 USD 4,180,801	57,563 -56.1%	72.63	USD 4,180,801
2019-11-20	2019-11-18	PS Planned sale	Lynch Karen S EVP & Pres, Aetna Bus Unit	80,143 -65.7% 75.00 USD 6,010,725	80,143 -65.7%	75.00	USD 6,010,725
2019-11-06	2019-11-04	PS Planned sale	Brennan Troyen A EVP and Chief Medical Officer Officer	23,604 -21.9% 68.00 USD 1,605,072	23,604 -21.9%	68.00	USD 1,605,072
2019-10-01	2019-09-30	PS Planned sale	Flum Joshua Matthew EVP, ENT STRATEGY & DIGITAL	17,703 -49.0% 63.00 USD 1,115,289	17,703 -49.0%	63.00	USD 1,115,289
2019-09-13	2019-09-12	PS Planned sale	Boratto Eva C EVP & CFO	8,130 -14.7% 65.00 USD 528,450	8,130 -14.7%	65.00	USD 528,450
2019-03-11	2019-03-11	B Purchase	BROWN C DAVID II	10,000 +9.9% 53.18 USD 531,800	10,000 +9.9%	53.18	USD 531,800
2019-03-11	2019-03-11	B Purchase	AGUIRRE FERNANDO	1,900 +13.3% 53.59 USD 101,821	1,900 +13.3%	53.59	USD 101,821
2019-03-11	2019-03-08	B Purchase	LUDWIG EDWARD J	2,000 +37.2% 52.80 USD 105,600	2,000 +37.2%	52.80	USD 105,600
2019-03-11	2019-03-08	B Purchase	DORMAN DAVID W Non-Executive Director	9,600 +8.5% 52.71 USD 506,016	9,600 +8.5%	52.71	USD 506,016
2019-03-04	2019-03-01	B Purchase	AGUIRRE FERNANDO	3,410 +31.2% 58.29 USD 198,769	3,410 +31.2%	58.29	USD 198,769
2019-03-04	2019-03-01	B Purchase	LUDWIG EDWARD J	4,000 +290.3% 58.27 USD 233,080	4,000 +290.3%	58.27	USD 233,080
2019-03-01	2019-03-01	S Sale	Clark James David SVP, Cont & Chief Acct Officer Officer	1,664 -19.4% 58.14 USD 96,745	1,664 -19.4%	58.14	USD 96,745

CVS Health Corp (CVS)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by